Q4 2022 Holdings
Filed 2023-02-03 | 44 holdings | $1.6B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-02-07) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Hillevax IncA | COM | 43157M102 | $163.3M | 9,758,359 | 10.2% |
| Imago Biosciences IncA | COM | 45250K107 | $143.3M | 3,987,207 | 8.9% |
| Arcutis Biotherapeutics Inc(ARQT)A | COM | 03969K108 | $128.5M | 8,684,232 | 8.0% |
| Chinook Therapeutics Inc(290A)A | COM | 16961L106 | $113.9M | 4,345,559 | 7.1% |
| Newamsterdam Pharma Company(NAMS)A | ORDINARY SHARES | N62509109 | $101.8M | 9,341,551 | 6.3% |
| Syndax Pharmaceuticals Inc(SNDX)A | COM | 87164F105 | $94.4M | 3,708,838 | 5.9% |
| Phathom Pharmaceuticals Inc(PHAT)A | COM | 71722W107 | $94.3M | 8,407,152 | 5.9% |
| Krystal Biotech Inc(KRYS)A | COM | 501147102 | $79.2M | 999,737 | 4.9% |
| Mirum Pharmaceuticals Inc(MIRM)A | COM | 604749101 | $75.3M | 3,860,107 | 4.7% |
| Verona Pharma PLC(VRNA)A | SPONSORED ADS | 925050106 | $73.6M | 2,815,720 | 4.6% |
| Vaxcyte Inc(PCVX)A | COM | 92243G108 | $67.0M | 1,397,405 | 4.2% |
| Rhythm Pharmaceuticals Inc(RYTM)A | COM | 76243J105 | $55.2M | 1,894,000 | 3.4% |
| Allakos Inc(ALLKGUSD)A | COM | 01671P100 | $40.3M | 4,792,000 | 2.5% |
| Anaptysbio Inc(ANAB)A | COM | 032724106 | $27.9M | 899,700 | 1.7% |
| Tarsus Pharmaceuticals Inc(TARS)A | COM | 87650L103 | $26.2M | 1,787,527 | 1.6% |
| Crinetics Pharmaceuticals in(CRNX)A | COM | 22663K107 | $25.9M | 1,414,823 | 1.6% |
| Replimune Group Inc(REPL)A | COM | 76029N106 | $25.3M | 931,560 | 1.6% |
| Cogent Biosciences Inc(COGT)A | COM | 19240Q201 | $24.4M | 2,109,154 | 1.5% |
| Alpine Immune Sciences Inc(NVLSEUR)A | COM | 02083G100 | $21.9M | 2,985,757 | 1.4% |
| Kalvista Pharmaceuticals Inc(KALV)A | COM | 483497103 | $21.9M | 3,238,859 | 1.4% |
| Gritstone BIO Inc(2JQ)A | COM | 39868T105 | $17.8M | 5,162,348 | 1.1% |
| Sutro Biopharma IncA | COM | 869367102 | $14.4M | 1,776,479 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD)A | COM | 004225108 | $13.6M | 857,338 | 0.8% |
| Silence Therapeutics PLC(SLN)A | ADS | 82686Q101 | $13.4M | 881,173 | 0.8% |
| Trevi Therapeutics Inc(TRVI)A | COM | 89532M101 | $12.9M | 6,663,590 | 0.8% |
| Cerevel Therapeutics Hldng I(CERE1EUR)A | COM | 15678U128 | $12.4M | 393,000 | 0.8% |
| Merus N VA | COM | N5749R100 | $11.5M | 746,479 | 0.7% |
| Vectivbio Hldg AGA | ORD SHS | H9060V101 | $11.5M | 1,333,400 | 0.7% |
| Avidity Biosciences Inc(RNA)A | COM | 05370A108 | $11.1M | 500,000 | 0.7% |
| Immunovant Inc(IMVT)A | COM | 45258J102 | $10.4M | 585,759 | 0.6% |
| Tyra Biosciences Inc(TYRA)A | COM | 90240B106 | $10.1M | 1,327,665 | 0.6% |
| Bluebird BIO IncA | COM | 09609G100 | $10.0M | 1,440,757 | 0.6% |
| Arvinas Inc(ARVN)A | COM | 04335A105 | $9.8M | 285,331 | 0.6% |
| Prothena Corp PLC(PRTA)A | SHS | G72800108 | $7.7M | 127,900 | 0.5% |
| Autolus Therapeutics PLC(AUTL)A | SPON ADS | 05280R100 | $7.1M | 3,746,857 | 0.4% |
| Intellia Therapeutics Inc(NTLA)A | COM | 45826J105 | $7.1M | 203,684 | 0.4% |
| Theseus Pharmaceuticals IncA | COM | 88369M101 | $7.0M | 1,398,194 | 0.4% |
| Passage BIO IncA | COM | 702712100 | $5.2M | 3,756,915 | 0.3% |
| Zymeworks del Inc(ZYME)A | COM | 98985Y108 | $4.8M | 610,000 | 0.3% |
| Aclaris Therapeutics Inc(ACRS)A | COM | 00461U105 | $4.6M | 290,189 | 0.3% |
| Essa Pharma Inc(EPIEUR)A | COM NEW | 29668H708 | $1.5M | 605,141 | 0.1% |
| Aptinyx IncA | COM | 03836N103 | $537.3K | 1,883,244 | 0.0% |
| Newamsterdam Pharma CompanyA | *W EXP 11/22/202 | N62509117 | $434.3K | 500,333 | 0.0% |
| Nabriva Therapeutics PLCA | SHS NEW 2022 | G63637139 | $32.2K | 17,025 | 0.0% |